Abstract PD17-05: Development and Validation of a Composite Biomarker Predictive of Palbociclib + Endocrine Treatment Benefit in Early Breast Cancer: PENELOPE-B and PALLAS Trials
Year: 2023
Type: conference-abstract
Source: Cancer Research
Authors: Sibylle Loibl, Carsten Denkert, Yuan Liu, Erik S. Knudsen, Angela DeMichele, Zhe Zhang, Julia Teply-Szymanski, Martin Filipits, Peter A. Fasching, Michael Gnant, Shibing Deng, Marija Balic, Federico Rojo, Mark Watson, Chetan Deshpande, Nicholas Turner, Otto Metzger, Kathy Puyana Theall, Agnieszka Witkiewicz, Olga Valota, W. Fraser Symmans, Erica L. Mayer
Institutions: German Breast Group, Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, Roswell Park Comprehensive Cancer Center, University of Pennsylvania, Pfizer (United States), Medical University of Vienna, Universitätsklinikum Erlangen, Medical University of Graz, Universidad Autónoma de Madrid, Royal Marsden Hospital, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4322769111